Diffusion MRI in prostate cancer with ultra-strong whole-body gradients

被引:0
|
作者
Molendowska, Malwina [1 ]
Palombo, Marco [1 ,2 ]
Foley, Kieran G. [3 ]
Narahari, Krishna [4 ]
Fasano, Fabrizio [5 ,6 ]
Jones, Derek K. [1 ]
Alexander, Daniel C. [7 ]
Panagiotaki, Eleftheria [7 ]
Tax, Chantal M. W. [1 ,8 ]
机构
[1] Cardiff Univ, Cardiff Univ Brain Res Imaging Ctr CUBR, Cardiff, Wales
[2] Cardiff Univ, Sch Comp Sci & Informat, Cardiff, Wales
[3] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, Wales
[4] Cardiff & Vale Univ Hlth Board, Heath Pk Campus, Cardiff, Wales
[5] Siemens Healthcare Ltd, Camberley, England
[6] Siemens Healthcare GmbH, Erlangen, Germany
[7] UCL, Ctr Med Image Comp, London, England
[8] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands
基金
英国工程与自然科学研究理事会; 英国科研创新办公室; 英国惠康基金;
关键词
diagnostic imaging; diffusion MRI; high b-values; prostate cancer; strong gradients; TISSUE; DISTORTIONS; RELAXATION; PARAMETERS;
D O I
10.1002/nbm.5229
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Diffusion-weighted MRI (dMRI) is universally recommended for the detection and classification of prostate cancer (PCa), with PI-RADS recommendations to acquire b-values of >= 1.4 ms/mu m(2). However, clinical dMRI suffers from a low signal-to-noise ratio (SNR) as the consequence of prolonged echo times (TEs) attributable to the limited gradient power in the range of 40-80 mT/m. To overcome this, MRI systems with strong gradients have been designed but so far have mainly been applied in the brain. The aim of this work was to assess the feasibility, data quality, SNR and contrast-to-noise ratio (CNR) of measurements in PCa with a 300 mT/m whole-body system. A cohort of men without and with diagnosed PCa were imaged on a research-only 3T Connectom Siemens MRI system equipped with a gradient amplitude of 300 mT/m. dMRI at high b-values were acquired using high gradient amplitudes and compared with gradient capabilities mimicking clinical systems. Data artefacts typically amplified with stronger gradients were assessed and their correction evaluated. The SNR gains and lesion-to-healthy tissue CNR were statistically tested investigating the effect of protocol and b-value. The diagnostic quality of the images for different dMRI protocols was assessed by an experienced radiologist using a 5-point Likert scale and an adapted PI-QUAL scoring system. The strong gradients for prostate dMRI allowed a significant gain in SNR per unit time compared with clinical gradients. Furthermore, a 1.6-2.1-fold increase in CNR was observed. Despite the more pronounced artefacts typically associated with strong gradients, a satisfactory correction could be achieved. Smoother and less biased parameter maps were obtained with protocols at shorter TEs. The results of this study show that dMRI in PCa with a whole-body 300-mT/m scanner is feasible without a report of physiological effects, SNR and CNR can be improved compared with lower gradient strengths, and artefacts do not negate the benefits of strong gradients and can be ameliorated. This assessment provides the first essential step towards unveiling the full potential of cutting-edge scanners, now increasingly becoming available, to advance early detection and diagnostic precision.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Cardiovascular whole-body MRI
    Kramer, Harald
    Nikolaou, Konstantin
    Reiser, Maximilian F.
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 70 (03) : 418 - 423
  • [22] Whole-body MRI of neuroblastoma
    Goo, Hyun Woo
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (03) : 306 - 314
  • [23] Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer
    Metser, Ur
    Chan, Rosanna
    Veit-Haibach, Patrick
    Ghai, Sangeet
    Tau, Noam
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (02) : 377 - 381
  • [24] PSMA-PET/CT AND WHOLE-BODY MRI FOR STAGING AND RESTAGING OF PROSTATE CANCER PATIENTS
    Greco, Elena
    Bianchi, Lorenzo
    Gaudiano, Cristina
    Corcioni, Beniamino
    Spinozzi, Luca
    Catanzaro, Calogero
    Mignogna, Chiara
    Renzetti, Benedetta
    Cattabriga, Arrigo
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Mosconi, Cristina
    Castellucci, Paolo
    Fanti, Stefano
    Farolfi, Andrea
    ANTICANCER RESEARCH, 2024, 44 (10)
  • [25] Additional value of whole-body MRI compared to PSMA PET in biochemically recurring prostate cancer
    Nys, A.
    Bidakhvidi, N. Ahmadi
    Jentjens, S.
    Laenen, A.
    Devos, G.
    Deroose, C. M.
    Everaerts, W.
    Joniau, S.
    Goffin, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S537 - S538
  • [26] Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI
    Larbi, A.
    Omoumi, P.
    Pasoglou, V
    Michoux, N.
    Triqueneaux, P.
    Tombal, B.
    Cyteval, C.
    Lecouvet, F. E.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2019, 100 (05) : 295 - 302
  • [27] Evaluation of whole-body MRI with diffusion-weighted sequences in the staging of pediatric cancer patients
    de Oliveira, Alex Dias
    Yto de Souza, Guilherme Heidi
    Brito de Figueiredo Guimaraes, Camila Pinto
    Guimaraes, Marcos Duarte
    Lima da Costa, Cecilia Maria
    de Gobbi Porto, Fabio Henrique
    Chojniak, Rubens
    PLOS ONE, 2020, 15 (08):
  • [28] Contrastive analysis of two energy gradients in the ultra-strong magnetic fields
    Weng, Zi-Hua
    INTERNATIONAL JOURNAL OF MODERN PHYSICS A, 2018, 33 (35):
  • [29] Automated prostate segmentation in whole-body MRI scans for epidemiological studies
    Habes, Mohamad
    Schiller, Thilo
    Rosenberg, Christian
    Burchardt, Martin
    Hoffmann, Wolfgang
    PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (17): : 5899 - 5915
  • [30] Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls
    Koh, Dow-Mu
    Blackledge, Matthew
    Padhani, Anwar R.
    Takahara, Taro
    Kwee, Thomas C.
    Leach, Martin O.
    Collins, David J.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 252 - 262